Published in Proc Natl Acad Sci U S A on December 01, 1991
Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J Virol (1995) 2.63
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol (1999) 2.07
The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol (1999) 1.80
The minimal replicator of Epstein-Barr virus oriP. J Virol (2000) 1.75
The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid (2007) 1.72
Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol (1999) 1.70
Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A (1991) 1.66
Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J Virol (1994) 1.64
Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J Virol (1997) 1.59
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol (2002) 1.58
Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol (1993) 1.55
Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J (1993) 1.53
Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. J Virol (1996) 1.44
Multiple regions within EBNA1 can link DNAs. J Virol (1995) 1.42
Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin. Mol Cell Biol (1995) 1.31
Looping dynamics of linear DNA molecules and the effect of DNA curvature: a study by Brownian dynamics simulation. Biophys J (1998) 1.31
The promoter of the Chinese hamster ovary dihydrofolate reductase gene regulates the activity of the local origin and helps define its boundaries. Genes Dev (2004) 1.30
Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J Virol (1993) 1.23
Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res (1998) 1.23
Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J Virol (2001) 1.21
Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines. J Virol (2000) 1.17
EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog (2009) 1.16
Spo0A, the key transcriptional regulator for entrance into sporulation, is an inhibitor of DNA replication. EMBO J (2006) 1.15
Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol (2013) 1.13
Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J Virol (2004) 1.13
Analysis of a replication initiation sequence from the adenosine deaminase region of the mouse genome. Mol Cell Biol (1993) 1.13
Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication. J Virol (1996) 1.08
Tension-dependent DNA cleavage by restriction endonucleases: two-site enzymes are "switched off" at low force. Proc Natl Acad Sci U S A (2006) 1.06
The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J (1996) 1.03
DNA looping by two-site restriction endonucleases: heterogeneous probability distributions for loop size and unbinding force. Nucleic Acids Res (2006) 1.02
Easily unwound DNA sequences and hairpin structures in the Epstein-Barr virus origin of plasmid replication. J Virol (1993) 0.99
Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathog (2009) 0.96
Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication. Nucleic Acids Res (2001) 0.96
Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication. J Virol (1993) 0.96
The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family. Proc Natl Acad Sci U S A (1994) 0.94
Ab initio thermodynamic modeling of distal multisite transcription regulation. Nucleic Acids Res (2007) 0.93
Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol (1998) 0.93
The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance. Virology (2003) 0.92
The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol (2001) 0.88
Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function. J Gen Virol (2009) 0.86
Dynamics of single DNA looping and cleavage by Sau3AI and effect of tension applied to the DNA. Biophys J (2006) 0.85
The Epstein-Barr Virus EBNA1 Protein. Scientifica (Cairo) (2012) 0.85
The dhfr oribeta-binding protein RIP60 contains 15 zinc fingers: DNA binding and looping by the central three fingers and an associated proline-rich region. Nucleic Acids Res (2000) 0.85
Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Viruses (2013) 0.84
Antigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatography. PLoS One (2009) 0.81
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. J Virol (2015) 0.79
Interference of the simian virus 40 origin of replication by the cytomegalovirus immediate early gene enhancer: evidence for competition of active regulatory chromatin conformation in a single domain. Mol Cell Biol (2000) 0.79
Structure and functional basis for an EBNA1 hexameric ring in Epstein-Barr Virus episome maintenance. J Virol (2017) 0.75
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science (1989) 25.68
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (1985) 14.39
Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem (1989) 11.73
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A (1984) 10.91
Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol (1976) 7.42
Facilitated target location in biological systems. J Biol Chem (1989) 7.18
Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell (1985) 7.17
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol (1985) 6.44
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol (1986) 6.00
Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol (1972) 4.66
The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell (1989) 4.16
Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol Cell Biol (1985) 4.03
DNA-looping and enhancer activity: association between DNA-bound NtrC activator and RNA polymerase at the bacterial glnA promoter. Proc Natl Acad Sci U S A (1990) 3.48
Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell (1991) 3.46
Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol (1989) 3.15
DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev (1991) 3.10
A bacterial enhancer functions to tether a transcriptional activator near a promoter. Science (1990) 2.93
P1 plasmid replication: replicon structure. J Mol Biol (1984) 2.84
Multipartite genetic control elements: communication by DNA loop. Annu Rev Genet (1989) 2.75
Use of polylysine for adsorption of nuclei acids and enzymes to electron microscope specimen films. Proc Natl Acad Sci U S A (1977) 2.67
DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci U S A (1991) 2.51
Interaction of the plasmid R6K-encoded replication initiator protein with its binding sites on DNA. Cell (1983) 2.48
Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J Virol (1989) 2.36
Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J Virol (1990) 2.35
An enhancer stimulates transcription in trans when attached to the promoter via a protein bridge. Cell (1989) 2.30
SV40 DNA replication. J Biol Chem (1988) 2.23
Enhancer-origin interaction in plasmid R6K involves a DNA loop mediated by initiator protein. Cell (1988) 2.21
Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J Biol Chem (1991) 2.06
DNA replication. J Biol Chem (1988) 1.85
Mini-P1 plasmid replication: the autoregulation-sequestration paradox. Cell (1988) 1.79
The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops. Proc Natl Acad Sci U S A (1991) 1.74
Nucleoprotein structures initiating DNA replication, transcription, and site-specific recombination. J Biol Chem (1990) 1.69
Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A (1991) 1.66
Binding of purified wild-type and mutant pi initiation proteins to a replication origin region of plasmid R6K. J Mol Biol (1986) 1.65
Transactivation of the Xenopus rRNA gene promoter by its enhancer. Nature (1989) 1.61
Transcriptional enhancers can act in trans. Trends Genet (1990) 1.38
On the nature of cis-acting regulatory proteins and genetic organization in bacteriophage: the example of gene Q of bacteriophage lambda. Genetics (1976) 1.23
Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis. Biochemistry (1973) 43.61
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (1985) 14.39
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A (1984) 10.91
Mammalian deoxyribonucleic acid-dependent ribonucleic acid polymerases. I. Purification and properties of an -amanitin-sensitive ribonucleic acid polymerase and stimulatory factors from HeLa and KB cells. J Biol Chem (1973) 8.86
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol (1985) 7.66
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature (1989) 7.60
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol (1985) 6.44
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol (1986) 6.00
Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature (1992) 5.92
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell (1988) 5.76
Control of phage lambda development by stability and synthesis of cII protein: role of the viral cIII and host hflA, himA and himD genes. Cell (1982) 5.48
Membrane association by bacteriophage lambda-DNA: possible direct role of regulator gene N. Nature (1969) 4.48
Multiple DNA-protein interactions governing high-precision DNA transactions. Science (1986) 3.97
Agarose slab-gel electrophoresis equipment. Anal Biochem (1975) 3.88
UmuD mutagenesis protein of Escherichia coli: overproduction, purification, and cleavage by RecA. Proc Natl Acad Sci U S A (1988) 3.85
DNA-looping and enhancer activity: association between DNA-bound NtrC activator and RNA polymerase at the bacterial glnA promoter. Proc Natl Acad Sci U S A (1990) 3.48
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene (1988) 3.42
Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol (1977) 3.11
DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev (1991) 3.10
A separate editing exonuclease for DNA replication: the epsilon subunit of Escherichia coli DNA polymerase III holoenzyme. Proc Natl Acad Sci U S A (1984) 3.05
Transcription of simian virus 40. 3. Mapping of "early" and "late" species of RNA. Proc Natl Acad Sci U S A (1973) 3.04
Glucose effect and the galactose enzymes of Escherichia coli: correlation between glucose inhibition of induction and inducer transport. J Bacteriol (1966) 2.97
Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol (1995) 2.91
DNA replication and messenger RNA production after induction of wild-type lambda bacteriophage and lambda mutants. J Mol Biol (1966) 2.90
Mutator strains of Escherichia coli, mutD and dnaQ, with defective exonucleolytic editing by DNA polymerase III holoenzyme. Proc Natl Acad Sci U S A (1983) 2.83
Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda: localized unwinding of duplex DNA by a six-protein reaction. Proc Natl Acad Sci U S A (1986) 2.79
Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol (1979) 2.78
The structure of the termini of the DNA of Epstein-Barr virus. Cell (1979) 2.69
Site-specific DNA condensation and pairing mediated by the int protein of bacteriophage lambda. Proc Natl Acad Sci U S A (1982) 2.67
Identification of the epsilon-subunit of Escherichia coli DNA polymerase III holoenzyme as the dnaQ gene product: a fidelity subunit for DNA replication. Proc Natl Acad Sci U S A (1983) 2.62
UmuC mutagenesis protein of Escherichia coli: purification and interaction with UmuD and UmuD'. Proc Natl Acad Sci U S A (1989) 2.52
Control of recA gene RNA in E. coli: regulatory and signal genes. Cell (1980) 2.51
ATP-dependent formation of a specialized nucleoprotein structure by simian virus 40 (SV40) large tumor antigen at the SV40 replication origin. Proc Natl Acad Sci U S A (1987) 2.49
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol (1995) 2.45
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
Mutants of bacteriophage lambda unable to integrate into the host chromosome. Proc Natl Acad Sci U S A (1967) 2.41
Using scenarios in chronic disease management guidelines for primary care. Proc AMIA Symp (2000) 2.36
Unwinding of duplex DNA from the SV40 origin of replication by T antigen. Science (1987) 2.35
Establishment and maintenance of repression by bacteriophage lambda: the role of the cI, cII, and c3 proteins. Proc Natl Acad Sci U S A (1971) 2.35
Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature (1981) 2.27
Control of large chromosomal duplications in Escherichia coli by the mismatch repair system. Genetics (1991) 2.25
New mutants of bacteriophage lambda with a specific defect in excision from the host chromosome. J Mol Biol (1970) 2.23
Purification and properties of the gamma-protein specified by bacteriophage lambda: an inhibitor of the host RecBC recombination enzyme. Proc Natl Acad Sci U S A (1973) 2.20
Capacity of RecA protein to bind preferentially to UV lesions and inhibit the editing subunit (epsilon) of DNA polymerase III: a possible mechanism for SOS-induced targeted mutagenesis. Proc Natl Acad Sci U S A (1986) 2.20
An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol (1995) 2.19
Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda: complexes with lambda O protein and with lambda O, lambda P, and Escherichia coli DnaB proteins. Proc Natl Acad Sci U S A (1985) 2.19
Amino acid sequence of Cro regulatory protein of bacteriophage lambda. Nature (1977) 2.18
Effect of circularity and superhelicity on transcription from bacteriophagelambda DNA. Proc Natl Acad Sci U S A (1973) 2.13
The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol (1989) 2.13
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol (2000) 2.12
SOS induction and autoregulation of the himA gene for site-specific recombination in Escherichia coli. Proc Natl Acad Sci U S A (1981) 2.08
Induction of the heat shock response of E. coli through stabilization of sigma 32 by the phage lambda cIII protein. Genes Dev (1987) 2.07
Developmental pathways for the temperate phage: lysis vs lysogeny,. Annu Rev Genet (1972) 2.07
Activity of the purified mutagenesis proteins UmuC, UmuD', and RecA in replicative bypass of an abasic DNA lesion by DNA polymerase III. Proc Natl Acad Sci U S A (1992) 2.03
The gamma protein specified by bacteriophage gamma. Structure and inhibitory activity for the recBC enzyme of Escherichia coli. J Biol Chem (1975) 2.01
Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol (1987) 1.95
The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene (1989) 1.94
Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu Rev Cell Biol (1987) 1.93
Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol (1997) 1.90
Integrative recombination function of bacteriophage lambda: evidence for a site-specific recombination enzyme. J Mol Biol (1968) 1.89
Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda. Protein association and disassociation reactions responsible for localized initiation of replication. J Biol Chem (1989) 1.85
The PRODIGY project--the iterative development of the release one model. Proc AMIA Symp (1999) 1.82
Properties of recombination-deficient mutants of bacteriophage lambda. J Mol Biol (1970) 1.80
The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol (1999) 1.80
Cro regulatory protein specified by bacteriophage lambda. Structure, DNA-binding, and repression of RNA synthesis. J Biol Chem (1977) 1.78
hflB, a new Escherichia coli locus regulating lysogeny and the level of bacteriophage lambda cII protein. J Mol Biol (1986) 1.78
Genetic control of transcription during development of phage gamma. Proc Natl Acad Sci U S A (1967) 1.78
The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J (1998) 1.73
Processive DNA synthesis by DNA polymerase II mediated by DNA polymerase III accessory proteins. J Biol Chem (1992) 1.72
SOS functions, cancer and inducible evolution. Cell (1981) 1.72
Mutation rate: some biological and biochemical considerations. Biochimie (1983) 1.70
DNA looping in cellular repression of transcription of the galactose operon. Genes Dev (1990) 1.70
Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro. Proc Natl Acad Sci U S A (1977) 1.68
EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol (1992) 1.66
Cleavage of the cII protein of phage lambda by purified HflA protease: control of the switch between lysis and lysogeny. Proc Natl Acad Sci U S A (1988) 1.64
Integrative and excisive recombination by bacteriophage lambda: evidence for an excision-specific recombination protein. J Mol Biol (1970) 1.61
Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J Virol (1997) 1.59
Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J Virol (1981) 1.59
Role of the cro gene in bacteriophage lambda development. J Mol Biol (1973) 1.58
Viral DNA in transformed cells. III. The amounts of different regions of the SV40 genome present in a line of transformed mouse cells. Proc Natl Acad Sci U S A (1974) 1.57
Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol (1995) 1.57
Inhibition by -amanitin of simian virus 40-specific ribonucleic acid synthesis in nuclei of infected monkey cells. J Virol (1972) 1.56
Inhibition of host nucleic acid synthesis by bacteriophage T4: effect of chloramphenicol at various multiplicities of infection. J Mol Biol (1966) 1.55
Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol (1994) 1.55
Purification and properties of a DNA-binding protein with characteristics expected for the Cro protein of bacteriophage lambda, a repressor essential for lytic growth. Proc Natl Acad Sci U S A (1976) 1.54
The general recombination system of bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1968) 1.54
The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene (2007) 1.52
Role of the Xis protein of bacteriophage lambda in a specific reactive complex at the attR prophage attachment site. Cell (1983) 1.51
Thermal asymmetry of site-specific recombination by bacteriophage lambda. Virology (1973) 1.51
Positive and negative regulation by the cII and cIII gene products of bacteriophage lambda. Virology (1975) 1.49
Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol (1994) 1.45
Immortalizing genes of Epstein-Barr virus. Adv Virus Res (1991) 1.45
Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol (1993) 1.44
Latency comes of age for herpesviruses. Cell (1988) 1.44
Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev Infect Dis (1983) 1.42
Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology (1974) 1.42